PGAM1 and cancer: Hitosugi et al. [274] identified three compounds through in vitro screening and obtained PGMI-004 after structural optimization; it can selectively inhibit PGAM1 activity, significantly inhibit glycolysis and PP in cancer cells, and reduce the synthesis of biomolecules such as nucleotides, amino acids, and lipids, while being less toxic to normal cells.